ICM
DRNA

ISZO Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

ISZO Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-123,200
Closed -$2.96M – 10
2015
Q1 		$2.96M Buy
+123,200
New +$2.77M 1.45% 7

Other funds holding DRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

ISZO Capital Management's DRNA Position: Q2 2015 in Review

ISZO Capital Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2015, closing a stake of 123,200 shares — an estimated $2.96M sold.

ISZO Capital Management first reported a position in DRNA in Q1 2015 and held it in 1 quarter. The position peaked at $2.96M in Q1 2015. 67 funds tracked by Wall St. Rank hold DRNA as of Q2 2015.

  • ISZO Capital Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • ISZO Capital Management sold 123,200 Dicerna Pharmaceuticals, Inc. shares in Q2 2015, an estimated $2.96M.
  • ISZO Capital Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • ISZO Capital Management's Dicerna Pharmaceuticals, Inc. position peaked at $2.96M in Q1 2015.
  • 67 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2015.

Based on ISZO Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.